Krismeikesari Krismeikesari 2025. Comparative Efficacy and Safety of Finerenone, Eplerenone, and Spironolactone on Cardiorenal Outcomes in Type 2 Diabetes with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. Open Access Indonesian Journal of Medical Reviews. 6, 1 (Nov. 2025), 1-20. DOI:https://doi.org/10.37275/oaijmr.v6i1.819.